- Home
- APM vs SCNX Comparison
APM vs SCNX Comparison
Compare APM & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APM
- SCNX
- Stock Information
- Founded
- APM 2010
- SCNX 2010
- Country
- APM United Kingdom
- SCNX United States
- Employees
- APM N/A
- SCNX N/A
- Industry
- APM Biotechnology: Pharmaceutical Preparations
- SCNX Other Pharmaceuticals
- Sector
- APM Health Care
- SCNX Health Care
- Exchange
- APM Nasdaq
- SCNX Nasdaq
- Market Cap
- APM 18.9M
- SCNX 21.2M
- IPO Year
- APM 2018
- SCNX 2020
- Fundamental
- Price
- APM N/A
- SCNX N/A
- Analyst Decision
- APM
- SCNX
- Analyst Count
- APM 0
- SCNX 0
- Target Price
- APM N/A
- SCNX N/A
- AVG Volume (30 Days)
- APM 434.9K
- SCNX 409.9K
- Earning Date
- APM 04-30-2025
- SCNX 11-05-2025
- Dividend Yield
- APM N/A
- SCNX N/A
- EPS Growth
- APM N/A
- SCNX N/A
- EPS
- APM N/A
- SCNX N/A
- Revenue
- APM N/A
- SCNX $128,202.00
- Revenue This Year
- APM N/A
- SCNX N/A
- Revenue Next Year
- APM N/A
- SCNX N/A
- P/E Ratio
- APM N/A
- SCNX N/A
- Revenue Growth
- APM N/A
- SCNX N/A
- 52 Week Low
- APM $0.46
- SCNX $0.69
- 52 Week High
- APM $7.49
- SCNX $9.55
- Technical
- Relative Strength Index (RSI)
- APM 62.63
- SCNX 34.48
- Support Level
- APM $1.74
- SCNX $0.81
- Resistance Level
- APM $2.50
- SCNX $0.89
- Average True Range (ATR)
- APM 0.17
- SCNX 0.05
- MACD
- APM 0.05
- SCNX 0.02
- Stochastic Oscillator
- APM 77.22
- SCNX 25.08
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.